Abundance and location of proteoglycans and hyaluronan within normal and myxomatous mitral valves

Cardiovascular Pathology

Volumn 18, Issue 4, 2009, Pages 191-197

  Gupta, Vishal ^a   Barzilla, Janet E ^a   Mendez, Joe S ^a   Stephens, Elizabeth H ^a   Lee, Elaine L ^a   Collard, C David ^b   Laucirica, Rodolfo ^b   Weigel, Paul H ^c   Grande Allen, Kathryn J ^a  

^a Rice University   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Extracellular matrix; Hyaluronan; Myxomatous mitral valve; Proteoglycan; Remodeling

Indexed keywords

BIGLYCAN; DECORIN; HYALURONIC ACID; PROTEOGLYCAN; VERSICAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; MALE; MITRAL VALVE; MITRAL VALVE DISEASE; MYXOMA; PRIORITY JOURNAL;

AGE FACTORS; AGED; CELL ADHESION MOLECULES, NEURONAL; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PROTEOGLYCANS; SEX FACTORS; VERSICANS;

EID: 67649354791     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2008.05.001     Document Type: Article

References (30)

1. Freed L.A., Acierno J.S., Dai D., Leyne M., Marshall J.E., Nesta F., Levine R.A., and Slaugenhaupt S.A. A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet 72 (2003) 1551-1559
2. Collins P., Cotton R.E., and Duff R.S. Symptomatic mitral myxomatous transformation in the elderly. Thorax 31 (1976) 765-770
3. Barber J.E., Kasper F.K., Ratliff N.B., Cosgrove D.M., Griffin B.P., and Vesely I. Mechanical properties of myxomatous mitral valves. J Thorac Cardiovasc Surg 122 (2001) 955-962
4. Nasuti J.F., Zhang P.J., Feldman M.D., Pasha T., Khurana J.S., Gorman III J.H., Gorman R.C., Narula J., and Narula N. Fibrillin and other matrix proteins in mitral valve prolapse syndrome. Ann Thorac Surg 77 (2004) 532-536
5. Akhtar S., Meek K.M., and James V. Ultrastructure abnormalities in proteoglycans, collagen fibrils, and elastic fibers in normal and myxomatous mitral valve chordae tendineae. Cardiovasc Pathol 8 (1999) 191-201
6. Rabkin E., Aikawa M., Stone J.R., Fukumoto Y., Libby P., and Schoen F.J. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 104 (2001) 2525-2532
7. Trochu J.N., Kyndt F., Schott J.J., Gueffet J.P., Probst V., Benichou B., and Le Marec H. Clinical characteristics of a familial inherited myxomatous valvular dystrophy mapped to xq28. J Am Coll Cardiol 35 (2000) 1890-1897
8. Olsen E.G., and Al-Rufaie H.K. The floppy mitral valve. Study on pathogenesis. Br Heart J 44 (1980) 674-683
9. Kinsella M.G., Bressler S.L., and Wight T.N. The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype. Crit Rev Eukaryot Gene Expr 14 (2004) 203-234
10. Wight T.N., Heinegard D., and Hascall V.C. Proteoglycans: structure and function. In: Hay E.D. (Ed). Cell Biology of Extracellular Matrix. 2nd ed. (1991), Plenum Press, New York 45-78
11. Grande-Allen K.J., Calabro A., Gupta V., Wight T.N., Hascall V.C., and Vesely I. Glycosaminoglycans and proteoglycans in normal mitral valve leaflets and chordae: association with regions of tensile and compressive loading. Glycobiology 14 (2004) 621-633
12. Reed C.C., and Iozzo R.V. The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj J 19 (2002) 249-255
13. Kresse H., and Schonherr E. Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 189 (2001) 266-274
14. Wight T.N. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 14 (2002) 617-623
15. Grande-Allen K.J., Griffin B.P., Ratliff N.B., Cosgrove D.M., and Vesely I. Glycosaminoglycan profiles of myxomatous mitral leaflets and chordae parallel the severity of mechanical alterations. J Am Coll Cardiol 42 (2003) 271-277
16. Grande-Allen K.J., Osman N., Ballinger M.L., Dadlani H., Marasco S., and Little P.J. Glycosaminoglycan synthesis and structure as targets for the prevention of calcific aortic valve disease. Cardiovasc Res 76 (2007) 19-28
17. Zhou B., Weigel J.A., Fauss L., and Weigel P.H. Identification of the hyaluronan receptor for endocytosis (HARE). J Biol Chem 275 (2000) 37733-37741
18. Zhou B., McGary C.T., Weigel J.A., Saxena A., and Weigel P.H. Purification and molecular identification of the human hyaluronan receptor for endocytosis. Glycobiology 13 (2003) 339-349
19. Falkowski M., Schledzewski K., Hansen B., and Goerdt S. Expression of stabilin-2, a novel fasciclin-like hyaluronan receptor protein, in murine sinusoidal endothelia, avascular tissues, and at solid/liquid interfaces. Histochem Cell Biol 120 (2003) 361-369
20. Fisher L.W., Stubbs III J.T., and Young M.F. Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand Suppl 266 (1995) 61-65
21. Lara S.L., Evanko S.P., and Wight T.N. Morphological evaluation of proteoglycans in cells and tissues. Methods Mol Biol 171 (2001) 271-290
22. Schonherr E., Jarvelainen H.T., Sandell L.J., and Wight T.N. Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem 266 (1991) 17640-17647
23. Radermecker M.A., Limet R., Lapiere C.M., and Nusgens B. Increased mRNA expression of decorin in the prolapsing posterior leaflet of the mitral valve. Interact Cardiovasc Thorac Surg 2 (2003) 389-394
24. Scott J.E. Proteoglycan-fibrillar collagen interactions. Biochem J 252 (1988) 313-323
25. Reinboth B., Hanssen E., Cleary E.G., and Gibson M.A. Molecular interactions of biglycan and decorin with elastic fiber components: biglycan forms a ternary complex with tropoelastin and microfibril-associated glycoprotein 1. J Biol Chem 277 (2002) 3950-3957
26. Kyosseva S.V., Harris E.N., and Weigel P.H. The hyaluronan receptor for endocytosis (HARE) mediates hyaluronan-dependent signal transduction via extracellular signal-regulated kinases (ERK). J Biol Chem 283 (2008) 15047-15055
27. Hellstrom M., Johansson B., and Engstrom-Laurent A. Hyaluronan and its receptor CD44 in the heart of newborn and adult rats. Anat Rec A Discov Mol Cell Evol Biol 288 (2006) 587-592
28. Savani R.C., Cao G., Pooler P.M., Zaman A., Zhou Z., and DeLisser H.M. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem 276 (2001) 36770-36778
29. Allison D.D., and Grande-Allen K.J. Hyaluronan: a powerful tissue engineering tool. Tissue Eng 12 (2006) 2131-2140
30. McDonald P.C., Wilson J.E., McNeill S., Gao M., Spinelli J.J., Rosenberg F., Wiebe H., and McManus B.M. The challenge of defining normality for human mitral and aortic valves: geometrical and compositional analysis. Cardiovasc Pathol 11 (2002) 193-209